Biogen Inc.BIIBNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank36
3Y CAGR+21.5%
5Y CAGR-11.6%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+21.5%/yr
vs -31.8%/yr prior
5Y CAGR
-11.6%/yr
Recent acceleration
Acceleration
+53.3pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.05B | -18.5% |
| 2024 | $2.52B | +103.6% |
| 2023 | $1.24B | +8.0% |
| 2022 | $1.14B | -66.2% |
| 2021 | $3.38B | -11.1% |
| 2020 | $3.81B | -42.0% |
| 2019 | $6.56B | +23.8% |
| 2018 | $5.30B | +43.9% |
| 2017 | $3.68B | -4.6% |
| 2016 | $3.86B | - |